Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Sources of Airborne Norovirus in Hospital Outbreaks.

Alsved M, Fraenkel CJ, Bohgard M, Widell A, Söderlund-Strand A, Lanbeck P, Holmdahl T, Isaxon C, Gudmundsson A, Medstrand P, Böttiger B, Löndahl J.

Clin Infect Dis. 2019 Jun 29. pii: ciz584. doi: 10.1093/cid/ciz584. [Epub ahead of print]

PMID:
31257413
2.

Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV).

Gray P, Luostarinen T, Vänskä S, Eriksson T, Lagheden C, Man I, Palmroth J, Pimenoff VN, Söderlund-Strand A, Dillner J, Lehtinen M.

Int J Cancer. 2019 Aug 1;145(3):785-796. doi: 10.1002/ijc.32189. Epub 2019 Feb 28.

PMID:
30719706
3.

Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III).

Lehtinen M, Luostarinen T, Vänskä S, Söderlund-Strand A, Eriksson T, Natunen K, Apter D, Baussano I, Harjula K, Hokkanen M, Kuortti M, Palmroth J, Petäjä T, Pukkala E, Rekonen S, Siitari-Mattila M, Surcel HM, Tuomivaara L, Paavonen J, Nieminen P, Dillner J, Dubin G, Garnett G.

Int J Cancer. 2018 Nov 1;143(9):2299-2310. doi: 10.1002/ijc.31618. Epub 2018 Aug 10.

PMID:
29845626
4.

Estimating effectiveness of HPV vaccination against HPV infection from post-vaccination data in the absence of baseline data.

Vänskä S, Söderlund-Strand A, Uhnoo I, Lehtinen M, Dillner J.

Vaccine. 2018 May 31;36(23):3239-3246. doi: 10.1016/j.vaccine.2018.04.073. Epub 2018 Apr 30.

PMID:
29716776
5.

Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II).

Gray P, Palmroth J, Luostarinen T, Apter D, Dubin G, Garnett G, Eriksson T, Natunen K, Merikukka M, Pimenoff V, Söderlund-Strand A, Vänskä S, Paavonen J, Pukkala E, Dillner J, Lehtinen M.

Int J Cancer. 2018 Jun 15;142(12):2491-2500. doi: 10.1002/ijc.31281. Epub 2018 Feb 12.

6.

Risk factors for hospital norovirus outbreaks: impact of vomiting, genotype, and multi-occupancy rooms.

Fraenkel CJ, Inghammar M, Söderlund-Strand A, Johansson PJH, Böttiger B.

J Hosp Infect. 2018 Apr;98(4):398-403. doi: 10.1016/j.jhin.2018.01.011. Epub 2018 Jan 31.

PMID:
29355578
7.

Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).

Lehtinen M, Söderlund-Strand A, Vänskä S, Luostarinen T, Eriksson T, Natunen K, Apter D, Baussano I, Harjula K, Hokkanen M, Kuortti M, Palmroth J, Petäjä T, Pukkala E, Rekonen S, Siitari-Mattila M, Surcel HM, Tuomivaara L, Paavonen J, Dillner J, Dubin G, Garnett G.

Int J Cancer. 2018 Mar 1;142(5):949-958. doi: 10.1002/ijc.31119. Epub 2017 Nov 9.

8.

Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16/18 Vaccination.

Lehtinen T, Söderlund-Strand A, Petäjä T, Eriksson T, Jokiranta S, Natunen K, Dillner J, Lehtinen M.

J Infect Dis. 2017 Nov 15;216(8):966-968. doi: 10.1093/infdis/jix415.

PMID:
28968844
9.

Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes.

Mesher D, Soldan K, Lehtinen M, Beddows S, Brisson M, Brotherton JM, Chow EP, Cummings T, Drolet M, Fairley CK, Garland SM, Kahn JA, Kavanagh K, Markowitz L, Pollock KG, Söderlund-Strand A, Sonnenberg P, Tabrizi SN, Tanton C, Unger E, Thomas SL.

Emerg Infect Dis. 2016 Oct;22(10):1732-40. doi: 10.3201/eid2210.160675. Review.

10.

Evaluation of human papillomavirus DNA detection in samples obtained for routine Chlamydia trachomatis screening.

Söderlund-Strand A, Wikström A, Dillner J.

J Clin Virol. 2015 Mar;64:88-91. doi: 10.1016/j.jcv.2015.01.008. Epub 2015 Jan 13.

PMID:
25728085
11.

Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring study.

Söderlund-Strand A, Uhnoo I, Dillner J.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2757-64. doi: 10.1158/1055-9965.EPI-14-0687. Epub 2014 Nov 7.

12.

Diversity of human papillomaviruses in skin lesions.

Ekström J, Mühr LS, Bzhalava D, Söderlund-Strand A, Hultin E, Nordin P, Stenquist B, Paoli J, Forslund O, Dillner J.

Virology. 2013 Dec;447(1-2):300-11. doi: 10.1016/j.virol.2013.09.010. Epub 2013 Oct 10.

13.

Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia.

Söderlund-Strand A, Kjellberg L, Dillner J.

J Med Virol. 2014 Apr;86(4):634-41. doi: 10.1002/jmv.23806. Epub 2013 Oct 12.

PMID:
24123176
14.

Patterns of human papillomavirus types in multiple infections: an analysis in women and men of the high throughput human papillomavirus monitoring study.

Vaccarella S, Söderlund-Strand A, Franceschi S, Plummer M, Dillner J.

PLoS One. 2013 Aug 19;8(8):e71617. doi: 10.1371/journal.pone.0071617. eCollection 2013.

15.

High-throughput monitoring of human papillomavirus type distribution.

Söderlund-Strand A, Dillner J.

Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):242-50. doi: 10.1158/1055-9965.EPI-12-1003. Epub 2012 Dec 5.

16.

Genotyping of human papillomavirus in triaging of low-grade cervical cytology.

Söderlund-Strand A, Eklund C, Kemetli L, Grillner L, Törnberg S, Dillner J, Dillner L.

Am J Obstet Gynecol. 2011 Aug;205(2):145.e1-6. doi: 10.1016/j.ajog.2011.03.056. Epub 2011 Apr 7.

PMID:
21658668
17.

Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus.

Söderlund-Strand A, Carlson J, Dillner J.

J Clin Microbiol. 2009 Mar;47(3):541-6. doi: 10.1128/JCM.02007-08. Epub 2009 Jan 14.

18.

High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry.

Söderlund-Strand A, Dillner J, Carlson J.

Clin Chem. 2008 Jan;54(1):86-92. Epub 2007 Nov 2.

19.

Supplemental Content

Loading ...
Support Center